India Animal Pharmaceuticals Market to Grow with a CAGR of 7.50% through 2030
Growing availability of veterinary
hospitals and clinics and growing occurrences of zoonotic diseases is expected
to drive the India Animal Pharmaceuticals Market growth in the forecast period,
2025-2029.
According to TechSci Research report, “India Animal
Pharmaceuticals Market -Industry Size, Share, Trends, Competition Forecast
& Opportunities, 2030”, India Animal Pharmaceuticals Market
has valued at USD 1.28 Billion in 2024 and is anticipated to project impressive
growth in the forecast period with a CAGR of 7.50% through 2030.
The India Animal Pharmaceuticals Market is experiencing significant growth,
driven by a range of factors. The increasing livestock population and the
rising incidence of animal diseases are augmenting the demand for animal
pharmaceuticals.
The growing pet adoption trend, coupled with rising
awareness about pet health among urban population, is also contributing to the
market expansion. Other drivers include technological advancements in animal
healthcare, government initiatives towards animal health, and the increasing
export of meat and dairy products.
Browse over XX market data Figures
spread through XX Pages and an in-depth TOC on "India Animal Pharmaceuticals Market.”
The Indian Animal Pharmaceuticals Market is a
fast-evolving and dynamic sector that holds a crucial and irreplaceable role in
the development, supply, and accessibility of medicines tailored specifically
for animal health. With continuous expansion and innovation, this flourishing
market covers a broad spectrum of pharmaceutical products that serve not only
pets and livestock but also a diverse range of animals, ensuring their overall
wellness and optimal health outcomes. The market offers a comprehensive array
of essential medications, such as vaccines, antibiotics, antiparasitics, feed
additives, and other therapeutic drugs, all designed to address the unique
health requirements of various animal species. These pharmaceutical
interventions play a vital role in promoting animal welfare and protecting
their health, thereby contributing significantly to food safety and national
food security.
Recent trends, including a sharp rise in pet ownership
and increased focus on livestock wellness, have propelled the Indian animal
pharmaceuticals market forward. The heightened awareness of zoonotic
diseases—those transmissible between animals and humans—has underscored the
necessity of investing in robust animal healthcare and disease prevention
strategies. Through the delivery of innovative and effective pharmaceutical
products, the Indian Animal Pharmaceuticals Market has become a vital and
irreplaceable pillar within the broader animal healthcare ecosystem. Its
critical contributions help advance animal life expectancy and well-being,
while simultaneously safeguarding the stability and sustainability of the food
supply chain. By consistently pursuing excellence and embracing technological
advancements, this market is well-positioned to elevate animal healthcare
standards, shaping a healthier future for both animals and people. This vibrant
and ever-expanding market offers abundant opportunities for both Indian and
global players. Driven by a growing animal husbandry industry, demand for
veterinary medicines and health products is accelerating. With India possessing
the world’s largest livestock population, the nation provides an especially
attractive environment for companies in the animal pharmaceuticals space.
Over the past ten years, the livestock sector’s
contribution to India’s GDP has witnessed notable growth, reflecting its
growing importance to the country's economy. This economic shift has
simultaneously increased the demand for veterinary solutions that can support
animal productivity and health. In response, investment in research,
manufacturing, and development of animal pharmaceutical products has gained
considerable momentum.
The Indian Animal Pharmaceuticals Market is primarily
segmented into poultry, dairy, and companion animals. The poultry and dairy
categories dominate market share, largely due to the significant consumption of
chicken, eggs, and dairy products nationwide. Meanwhile, the companion animal
segment, although relatively smaller, is experiencing rapid growth thanks to a
surge in pet ownership and rising expenditure on pet health and wellness.
Indian companies operating in this field benefit from
the country's robust pharmaceutical manufacturing infrastructure. As one of the
leading global producers of generic drugs, India is well-positioned to leverage
its capabilities to develop high-quality, cost-effective animal health
products. This strong manufacturing base enables companies to scale production
and meet both domestic and international demand efficiently. This growing
international interest highlights the global community’s acknowledgment of
India’s market potential. As domestic demand rises and policy frameworks
mature, India is poised to become a key player in the global animal health
landscape.
The Indian Animal Pharmaceuticals Market, supported by
strong demand and a deepening focus on animal wellness, is a critical sector
for national development. With targeted strategies, innovation, and effective
resolution of existing challenges, the market offers tremendous potential for
all involved stakeholders—from pharmaceutical companies and healthcare
providers to farmers and pet owners.
The India Animal Pharmaceuticals Market is segmented
into product type, product, animal type, registration, regional distribution,
and company.
Based on registration, in the Indian animal
pharmaceuticals market, patented drugs currently hold dominance over generic
ones. This trend is primarily driven by the robust research and development
efforts undertaken by pharmaceutical companies, where they invest substantial
resources in developing innovative drugs and securing patent rights to protect
their investments and capitalize on their innovations. However, the market
dynamic is gradually shifting towards generic drugs. This shift can be attributed
to several factors, including the expiration of several key patents, which
paves the way for generic alternatives to enter the market. The increasing
demand for affordable and effective animal pharmaceuticals has contributed to
the rising popularity of generic drugs. Their affordability makes them more
accessible to a wider range of consumers, which further fuels their demand and
adoption in the market. As the demand for affordable and effective animal
pharmaceuticals continues to grow, the market landscape is expected to evolve
further. While patented drugs still hold a dominant position, the rise of
generic drugs represents a significant shift in the industry. This changing
dynamic presents both challenges and opportunities for pharmaceutical companies
as they navigate the delicate balance between innovation, patent protection,
and market demand.
Based on region, the fastest-growing zone in the
Indian Animal Pharmaceuticals Market is South India, driven by a strong
presence of poultry and dairy farming, increasing pet ownership, and
well-established veterinary infrastructure. States like Andhra Pradesh, Tamil
Nadu, Karnataka, and Telangana are witnessing rapid growth due to their large
livestock populations, high consumption of animal-based products, and
government support for animal health initiatives. Andhra Pradesh and Tamil Nadu
are leading poultry hubs, contributing significantly to the demand for
antibiotics, vaccines, and feed additives. The urban centers like Bengaluru and
Hyderabad have seen a rise in companion animal care, fueling growth in pet
pharmaceuticals. The presence of several veterinary research institutes and
pharmaceutical manufacturing units in this region further boosts innovation and
supply chain efficiency. With increasing awareness, better access to veterinary
care, and ongoing investments in livestock productivity, South India is
emerging as a critical and dynamic growth engine for the country’s animal
health sector.
Major companies operating in India
Animal Pharmaceuticals Market are:
·
SeQuent Scientific Limited
·
Elanco India Private Limited
·
Merck Animal Health
·
Phibro Animal Health Limited
·
Boehringer Ingelheim Animal Health
·
Zoetis India Limited
·
Virbac Animal Health India Private Limited
·
Vetoquinol India Animal Health Private Limited
·
Perrigo Laboratories India Private Limited
·
Bayer (India) Limited
Download Free Sample Report
Customers can also request for 10%
free customization on this report.
“The animal pharmaceuticals market in India is poised
for strong growth, driven by several key factors. Rising cases of animal
diseases and a growing livestock population, fueled by demand for animal-based
products, are major contributors. Increased awareness of animal health and
supportive government initiatives are further accelerating market momentum. Advancements
in veterinary healthcare, including new vaccines and medications, are enhancing
treatment options. These trends collectively signal a promising future for
India’s animal pharmaceutical sector” said Mr. Karan Chechi, Research Director
with TechSci Research, a research-based management consulting firm.
“India Animal Pharmaceuticals Market By Product Type
(Vaccine, Parasiticides, Anti-Infectives, Others), By Product
[Ectoparasiticides (Ivermectin, Cypermethrin, Fipronil, Coumaphos, Others)
Endoparasiticides (Ivermectin, Praziquantel, Flubendazole, Milbemycin,
Levamisole, Fenbendazole, Pyrantel, Others) Anti-Inflammatories (NSAIDs,
Corticosteroids, Others) Bronchodilators (Theophylline, Albuterol, Others)], By
Animal Type (Companion Animals, Livestock), By Registration (Generic,
Patented), By Region, Competition, Forecast & Opportunities, 2020-2030F”,
has evaluated the future growth potential of India Animal Pharmaceuticals
Market and provides statistics & information on market size, structure and
future market growth. The report intends to provide cutting-edge market
intelligence and help decision makers take sound investment decisions. Besides,
the report also identifies and analyzes the emerging trends along with
essential drivers, challenges, and opportunities in India Animal
Pharmaceuticals Market.
Contact
TechSci
Research LLC
420
Lexington Avenue, Suite 300,
New
York, United States- 10170
Tel: +1-332-258-6602
Email: sales@techsciresearch.com
Website: www.techsciresearch.com